578
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

The effect of ionizing radiation on the subcellular localization and kinase activity of protein kinase CK2 in human non-small cell lung cancer cells

, , , , , , , , & show all
Pages 1462-1471 | Received 24 Oct 2017, Accepted 27 Jun 2019, Published online: 23 Jul 2019

References

  • Ahmed K, Gerber DA, Cochet C. 2002. Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol. 12:226–230.
  • Allende JE, Allende CC. 1995. Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. FASEB J. 9:313–323.
  • Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB, Cochet C, Issinger OG, Boldyreff B. 2003. Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol. 23:908–915.
  • Carroll D, Marshak DR. 1989. Serum-stimulated cell growth causes oscillations in casein kinase II activity. J Biol Chem. 264:7345–7348.
  • Davis AT, Wang H, Zhang P, Ahmed K. 2002. Heat shock mediated modulation of protein kinase CK2 in the nuclear matrix. J Cell Biochem. 85:583–591.
  • Duncan JS, Litchfield DW. 2008. Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim Biophys Acta. 1784:33–47.
  • Dutta A, Eckelmann B, Adhikari S, Ahmed KM, Sengupta S, Pandey A, Hegde PM, Tsai MS, Tainer JA, Weinfeld M, et al. 2017. Microhomology-mediated end joining is activated in irradiated human cells due to phosphorylation-dependent formation of the XRCC1 repair complex. Nucleic Acids Res. 45:2585–2599.
  • Faust M, Schuster N, Montenarh M. 1999. Specific binding of protein kinase CK2 catalytic subunits to tubulin. FEBS Lett. 462:51–56.
  • Filhol O, Nueda A, Martel V, Gerber-Scokaert D, Benitez MJ, Souchier C, Saoudi Y, Cochet C. 2003. Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits. Mol Cell Biol. 23:975–987.
  • Guerra B, Issinger OG. 1999. Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis. 20:391–408.
  • Guerra B, Iwabuchi K, Issinger OG. 2014. Protein kinase CK2 is required for the recruitment of 53BP1 to sites of DNA double-strand break induced by radiomimetic drugs. Cancer Lett. 345:115–123.
  • Hanna DE, Rethinaswamy A, Glover CV. 1995. Casein kinase II is required for cell cycle progression during G1 and G2/M in Saccharomyces cerevisiae. J Biol Chem. 270:25905–25914.
  • Hsieh WT, Lin HY, Chen JH, Lin WC, Kuo YH, Wood WG, Lu HF, Chung JG. 2015. Latex of Euphorbia antiquorum-induced S-phase arrest via active ATM kinase and MAPK pathways in human cervical cancer HeLa cells. Environ Toxicol. 30:1205–1215.
  • Koch CA, Agyei R, Galicia S, Metalnikov P, O’Donnell P, Starostine A, Weinfeld M, Durocher D. 2004. Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV. Embo J. 23:3874–3885. English.
  • Korn I, Jacob G, Allende CC, Allende JE. 2001. The activity of CK2 in the extracts of COS-7 cells transfected with wild type and mutant subunits of protein kinase CK2. Mol Cell Biochem. 227:37–44.
  • Kroonen J, Artesi M, Capraro V, Nguyen-Khac MT, Willems M, Chakravarti A, Bours V, Robe PA. 2012. Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma nant glioma cells. Int J Oncol. 41:776–782.
  • Lee IY, Lin YY, Yang YH, Lin YS, Lin CL, Lin WY, Cheng YC, Shu LH, Wu CY. 2018. Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway. BMC Pharm Toxicol. 19:5.
  • Li Q, Li K, Yang T, Zhang S, Zhou Y, Li Z, Xiong J, Zhou F, Zhou X, Liu L, et al. 2017. Association of protein kinase CK2 inhibition with cellular radiosensitivity of non-small cell lung cancer. Sci Rep. 7:16134
  • Lin YC, Hung MS, Lin CK, Li JM, Lee KD, Li YC, Chen MF, Chen JK, Yang CT. 2011. CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of stat3 activation. Cancer Biother Radiopharm. 26:381–388.
  • Litchfield DW. 2003. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J. 369:1–15.
  • Litchfield DW, Luscher B. 1993. Casein kinase II in signal transduction and cell cycle regulation. Mol Cell Biochem. 127/128:187–199.[10.1007/978-1-4615-2600-1_18]
  • McKendrick L, Milne D, Meek D. 1999. Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable. Mol Cell Biochem. 191:187–199.
  • Meggio F, Pinna LA. 2003. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17:349–368.
  • Meng R, Gotz C, Montenarh M. 2010. The role of protein kinase CK2 in the regulation of the insulin production of pancreatic islets. Biochem Biophys Res Commun. 401:203–206.
  • Olsen BB, Wang SY, Svenstrup TH, Chen BP, Guerra B. 2012. Protein kinase CK2 localizes to sites of DNA double-strand break regulating the cellular response to DNA damage. BMC Mol Biol. 13:7.
  • Pan X, Meng R, Yu Z, Mou J, Liu S, Sun Z, Zou Z, Wu G, Peng G. 2016. Quinalizarin enhances radiosensitivity of nasopharyngeal carcinoma cells partially by suppressing SHP-1 expression. Int J Oncol. 48:1073–1084.
  • Parsons JL, Dianova II, Finch D, Tait PS, Strom CE, Helleday T, Dianov GL. 2010. XRCC1 phosphorylation by CK2 is required for its stability and efficient DNA repair. DNA Repair (Amst). 9:835–841.
  • Pinna LA, Meggio F. 1997. Protein kinase CK2 (“casein kinase-2 and its implication in cell division and proliferation”). Prog Cell Cycle Res. 3:77–97.
  • Seldin DC, Lou DY, Toselli P, Landesman-Bollag E, Dominguez I. 2008. Gene targeting of CK2 catalytic subunits. Mol Cell Biochem. 316:141–147.
  • Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y. 2007. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell. 128:157–170.
  • Sommercorn J, Mulligan JA, Lozeman FJ, Krebs EG. 1987. Activation of casein kinase II in response to insulin and to epidermal growth factor. Proc Natl Acad Sci USA. 84:8834–8838.
  • Spycher C, Miller ES, Townsend K, Pavic L, Morrice NA, Janscak P, Stewart GS, Stucki M. 2008. Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin. J Cell Biol. 181:227–240.
  • Tawfic S, Ahmed K. 1994. Growth stimulus-mediated differential translocation of casein kinase 2 to the nuclear matrix. Evidence based on androgen action in the prostate. J Biol Chem. 269:24615–24620.
  • Theis-Febvre N, Martel V, Laudet B, Souchier C, Grunwald D, Cochet C, Filhol O. 2005. Highlighting protein kinase CK2 movement in living cells. Mol Cell Biochem. 274:15–22.
  • Trembley JH, Wang G, Unger G, Slaton J, Ahmed K. 2009. Protein kinase CK2 in health and disease: CK2: a key player in cancer biology. Cell Mol Life Sci. 66:1858–1867.
  • Welker S, Gotz C, Servas C, Laschke MW, Menger MD, Montenarh M. 2013. Glucose regulates protein kinase CK2 in pancreatic β-cells and its interaction with PDX-1 . Int J Biochem Cell Biol. 45:2786–2795.
  • Xu B, Kim ST, Lim DS, Kastan MB. 2002. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol. 22:1049–1059.
  • Xu X, Toselli PA, Russell LD, Seldin DC. 1999. Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit. Nat Genet. 23:118–121.
  • Yamane K, Kinsella TJ. 2005. CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation. Cancer Res. 65:4362–4367.
  • Yaylim I, Isbir T. 2002. Enhanced casein kinase II (CK II) activity in human lung tumours. Anticancer Res. 22:215–218.
  • Zwicker F, Ebert M, Huber PE, Debus J, Weber KJ. 2011. A specific inhibitor of protein kinase CK2 delays gamma-H2Ax foci removal and reduces clonogenic survival of irradiated mammalian cells. Radiat Oncol. 6:15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.